In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Execs On The Move, July-August 2014

Executive Summary

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

You may also be interested in...



Game Time: FDA Releases Review Timeline Goals Set By MDUFA V

This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.

Nested Therapeutics Targets Mutations Hiding In Plain Sight

Newly launched with a $90m series A funding round, the company is taking the idea behind KRAS G12C inhibitors to another level.

Not Just The Result Of Contact Sports And Combat

A pair of medical experts discuss traumatic brain injuries, their treatments, and some of the long-term complications they can cause, especially when not properly diagnosed and treated. 

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

IV004255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel